Overall market sentiment has been high on Oncology Institute Inc (TOI) stock lately. TOI receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.
Oncology Institute Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TOI!
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With TOI Stock Today?
Oncology Institute Inc (TOI) stock is trading at $2.36 as of 10:12 AM on Friday, Nov 10, an increase of $0.01, or 0.43% from the previous closing price of $2.35. Volume today is 175,232 compared to average volume of 204,233. The stock has traded between $2.35 and $2.50 so far today.
To screen for more stocks like Oncology Institute Inc click here.
More About Oncology Institute Inc
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
Click Here to get the full Stock Report for Oncology Institute Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
